Loading...
Market
Will TPOXX receive FDA approval for a new indication by end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA official announcements
Story
Siga Technologies Wins Third $9M Contract in Three Years with U.S. Defense for TPOXX
Aug 21, 2024, 08:02 PM
Siga Technologies has been awarded a $9 million contract by the U.S. Department of Defense for the procurement of its smallpox treatment, TPOXX. This contract marks the third awarded to Siga by the Department of Defense in the last three years. The collaboration between Siga Technologies and the Department of Defense also includes support for the PEP indication through a $27 million development contract.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
